Chardan Capital Brokers Increase Earnings Estimates for UBX
Unity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Investment analysts at Chardan Capital boosted their FY2025 EPS estimates for Unity Biotechnology in a report issued on Monday, March 10th. Chardan Capital analyst D. Gataulin now anticipates that the company will earn ($0.72) per share for the year, up from their previous estimate of ($0.74). Chardan […]
Unity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Investment analysts at Chardan Capital boosted their FY2025 EPS estimates for Unity Biotechnology in a report issued on Monday, March 10th. Chardan Capital analyst D. Gataulin now anticipates that the company will earn ($0.72) per share for the year, up from their previous estimate of ($0.74). Chardan […]
